Sinopharm
1099.HK
#2275
Rank
โ‚น722.78 B
Marketcap
โ‚น231.61
Share price
0.96%
Change (1 day)
1.10%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.223 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.223 Trillion. In 2024 the company made a revenue of โ‚น7.223 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.612 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.223 T-5.1%
2023โ‚น7.612 T5.42%
2022โ‚น7.220 T-2.1%
2021โ‚น7.375 T16.85%
2020โ‚น6.311 T14.95%
2019โ‚น5.490 T21.52%
2018โ‚น4.518 T5.93%
2017โ‚น4.265 T27.22%
2016โ‚น3.352 T5.37%
2015โ‚น3.181 T9.14%
2014โ‚น2.915 T17.22%
2013โ‚น2.486 T25.94%
2012โ‚น1.974 T34.61%
2011โ‚น1.466 T55.34%
2010โ‚น944.34 B35.79%
2009โ‚น695.45 B37.56%
2008โ‚น505.57 B31.43%
2007โ‚น384.68 B40.26%
2006โ‚น274.26 B